US biotech Response Pharmaceuticals (Nasdaq: RSPN) has unveiled top-line Phase II results for its experimental obesity ...

Results from a Phase II trial (NCT06640972) showed that patients treated with RDX-002 experienced significant reductions in ...

Response is also considering running trials of the weight management drug RDX-002 in combination with GLP-1RA therapies.

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

RDX-002, a novel iMTP inhibitor, showed promising results in a Ph2 study, reducing blood fat and weight regain after GLP-1 ...

Taking weight off with a glucagon-like peptide-1 (GLP-1) receptor agonist and keeping it off once the drug has been discontinued has been a tall order but Response Pharmaceuticals Inc. is seeing ...

Among the prominent players are Intrabio Inc., Niagen Bioscience Inc., and Quince Therapeutics Inc. Typically, A-T is first diagnosed before the age of 5 as children begin to develop an altered gait.

7/11 blasts: HC disbelieved recovery of RDX on hyper-technical ground, Maha govt tells SC | Latest News India ...

The Bombay Stock Exchange (BSE) in Mumbai faced a bomb threat on Tuesday, triggering a swift security response. An email, purportedly from "Comrade Pinarayi Vijayan," warned of RDX IEDs set to ...

Acura's refresh of the 2025 RDX doesn't mess with a winning formula. Well, apart from one lingering frustration, maybe.

Acura ADX vs Acura RDX: Which model and trim should you buy? | Reviews The baby Acura might have won five of our seven performance categories, but it doesn't mean it has won the battle ...

Read our 2026 Acura RDX review for information on ratings, pricing, specs, and features, and see how this SUV performed in our testing.